Cardiac tumors pose a unique and uncommon challenge within the realm of cardiovascular health. These growths, characterized by the abnormal multiplication of cells in the heart, can manifest as either benign or malignant. Originating within the heart itself (primary tumors) or spreading from other parts of the body (secondary tumors), cardiac tumors present a diverse range of symptoms, from chest pain and shortness of breath to irregular heartbeats and persistent fatigue. Diagnosis often involves a sophisticated blend of imaging techniques such as echocardiography and cardiac MRI, coupled with invasive biopsy procedures. Tailored treatment plans, determined by the type, size, and location of the tumor, may encompass surgical intervention, chemotherapy, or radiation therapy. Given their rarity, ongoing research endeavors strive to unravel the intricacies of cardiac tumors, shedding light on their causes, risk factors, and optimal therapeutic approaches. Early detection remains pivotal, serving as a critical factor in enhancing outcomes and mitigating potential impacts on cardiac function.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States